Zionexa has signed an exclusive agreement with PETNET Solutions Inc. for manufacturing and distribution
Zionexa and PETNET have entered into an exclusive agreement for the manufacturing and distribution of Zionexa’s new PET diagnostic drug, Fluoroestradiol (FES)